Stoke Therapeutics Inc Cash Flow Reinvestment Rate

Latest as of March 2025: 0.10x

Stoke Therapeutics Inc cash flow reinvestment rate. Stoke Therapeutics Inc (STOK) has a Cash Flow Reinvestment Rate of 0.10x as of March 2025, reinvesting $13.78 Million (capex $152.00K plus investments $13.63 Million) from operating cash flow of $131.83 Million. Explore STOK cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.10x

(Capex + Investments) / Operating CF

Total Reinvested

$13.78 Million

Capex + Investments

Operating Cash Flow

$131.83 Million

USD

Capital Expenditures

$152.00K

USD

Cash Flow Reinvestment Rate of Stoke Therapeutics Inc (2025–2025)

Cash flow reinvestment rate of Stoke Therapeutics Inc from 2025 to 2025. Historical reinvestment intensity for Stoke Therapeutics Inc across 1 annual periods. Explore STOK capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

Stoke Therapeutics Inc Cash Flow Reinvestment Rate by Year (2025–2025)

Stoke Therapeutics Inc cash flow reinvestment rate by year from 2025 to 2025. Year-by-year capital reinvestment analysis for Stoke Therapeutics Inc. For the full cash flow conversion analysis, see Stoke Therapeutics Inc (STOK) cash conversion ratio.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change
2025	4.10x	$186.81 Million	$45.59 Million	$670.00K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow